Krystal Biotech (KRYS) Change in Taxes (2024 - 2026)

Krystal Biotech has disclosed Change in Taxes across 3 years of filings, most recently posting -$3.4 million for Q1 2026.

• Change in Taxes for Q1 2026 came in at -$3.4 million, down 636.32% year-over-year; the trailing twelve-month figure through Mar 2026 was -$565000.0 (changed N/A YoY), and the FY2025 annual result was $12.4 million, up 666.17% from the prior year.
• Change in Taxes came in at -$3.4 million for Q1 2026 at Krystal Biotech, down from $2.3 million in the prior quarter.
• In the past five years, Change in Taxes ranged from a high of $2.3 million in Q4 2025 to a low of -$3.4 million in Q1 2026.
• The 3-year median for Change in Taxes is $257000.0 (2024), against an average of -$141250.0.
• Across the five-year window, Change in Taxes surged 135.43% in 2025 and sank 636.32% in 2026, its largest moves.
• Krystal Biotech's Change in Taxes stood at $971000.0 in 2024, then surged by 135.43% to $2.3 million in 2025, then plunged by 247.2% to -$3.4 million in 2026.
• The last three Change in Taxes figures came in at -$3.4 million (Q1 2026), $2.3 million (Q4 2025), and -$457000.0 (Q1 2025), per Business Quant data.